Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Symbyax Journal Ad Features Drawing Of Patient Heading "Into The Light"

This article was originally published in The Pink Sheet Daily

Executive Summary

The reminder ad shows a patient being led by a doctor out of a dense and dark forest into a bright clearing. The spot is part of the product's physician-directed campaign and is not in response to a slower-than-expected launch of the bipolar depression agent, Lilly says.

You may also be interested in...



Arcoxia "Coming Soon" Journal Ads Running As User Fee Date Approaches

The ad first appeared in medical journals in early September, well ahead of the Oct. 30 PDUFA date for the COX-2 inhibitor. Merck says the ad does not reflect expectations of a particular FDA review decision but rather is standard industry practice.

Arcoxia "Coming Soon" Journal Ads Running As User Fee Date Approaches

The ad first appeared in medical journals in early September, well ahead of the Oct. 30 PDUFA date for the COX-2 inhibitor. Merck says the ad does not reflect expectations of a particular FDA review decision but rather is standard industry practice.

Zyprexa Marketing Goes "Back to Basics"

Lilly strategy will focus on identifying patients, promoting new indications/formulations and preserving access. Company acknowledges that combating negative safety impression for the antipsychotic is "not an easy task."

Topics

UsernamePublicRestriction

Register

MT142539

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel